99,5 %Near-universal resistance (99.5%) was observed for itraconazole among Candida isolates.
Nigeriaoral candidiasis · VIH/sidapublié 2026BMC infectious diseasesPubMeddocument de 11 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
1 729 evidences · page 52 / 70
99,5 %Near-universal resistance (99.5%) was observed for itraconazole among Candida isolates.
Nigeriaoral candidiasis · VIH/sidapublié 2026BMC infectious diseasesPubMeddocument de 11 observations
16 %At baseline, the proportion of type B tympanogram was 16.0% in the right ear and 15.3% in the left ear among 150 HIV-positive patients.
NigeriaVIH/sidapublié 2023Nigerian journal of clinical practicePubMeddocument de 6 observations
35,9 %The CYP2B6:516 G/G genotype frequency was 35.9% among participants with genotype results.
NigeriaVIH/sidapublié 2020Nigerian journal of clinical practicePubMeddocument de 8 observations
0 %The prevalence of the HLA-B*57:01 allele among 1458 successfully typed HIV-positive adults in Nigeria was 0%.
NigeriaVIH/sidaobservé April 2016 to April 2017publié 2019The Nigerian postgraduate medical journalPubMeddocument de 6 observations
Hemoglobin genotype distribution among HIV-1 patients was comparable to that in the general population of Nigeria.
NigeriaVIH/sidapublié 2022The open AIDS journaleurope_pmcdocument de 3 observations
0,1 daysParticipants in the point-of-care arm received viral load results significantly faster than those in the standard-of-care arm, with a median of 0.1 days (interquartile range 0.1–0.2) versus 143.1 days (interquartile range 56.0–177.1), respectively.
NigeriaVIH/sidaobservé April 2018 to October 2019publié 2023Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument de 2 observations
26 %Nigeria's widespread mixed epidemiology HIV program has achieved a 26% reduction in new HIV infections since 2010.
NigeriaVIH/sidaobservé since 2010publié 2023Sexual healthPubMed
27,7 %Only 27.7% of respondents in the control group increased their HIV/AIDS knowledge post-test.
NigeriaVIH/sidapublié 2024BMC public healthPubMeddocument de 5 observations
60 daysAmong those not retained, mean days to be lost-to-follow up was 60 days.
NigeriaVIH/sidapublié 2025BMC public healthPubMeddocument de 8 observations
5,07 %The rate of new HIV infection among blood donors in this study was 5.07%.
NigeriaVIH/sidapublié 2021Journal of medical virologyPubMeddocument de 11 observations
1,67 risk_ratioHaving viral load < 50 copies/mL was associated with HIV status disclosure to male sexual partners (RR 1.67 [95% CI 1.24–2.25]).
NigeriaVIH/sidapublié 2020BMC public healthPubMeddocument de 6 observations
4,14 AORThe adjusted odds ratio for repeat HIV testing among HIV-negative pregnant women at term referred by TBAs in cluster 1 was 4.14 (95% CI [2.82–5.99]).
NigeriaVIH/sidapublié 2024BMC pregnancy and childbirthPubMeddocument de 8 observations
2,525 odds_ratioHIV-positive children were more likely to have intestinal helminthiasis than HIV-negative children, with an odds ratio of 2.525.
Nigeriaintestinal helminthiasis · VIH/sidapublié 2024Nigerian journal of clinical practicePubMeddocument de 4 observations
50 casesFifty (98.0%) low risk infants had HIV DNA PCR testing between 6–8 weeks.
NigeriaVIH/sidapublié 2025West African journal of medicinePubMeddocument de 8 observations
7,1 %The rate of mother-to-child transmission of HIV infection was 7.1% as previously reported by the center.
NigeriaVIH/sidapublié 2023Japanese journal of infectious diseasesPubMeddocument de 5 observations
Female sex workers in Nigeria carry a disproportionate Human Immunodeficiency Virus (HIV) burden.
NigeriaVIH/sidapublié 2026BMC public healthPubMeddocument de 3 observations
438 clients438 out of the 562 (78%) returnee PLHIV gave consent and participated in the study.
NigeriaVIH/sidapublié 2019AIDS research and therapyPubMeddocument de 14 observations
121 individualsThe study included 121 consecutive children with HIV/AIDS on HAART.
NigeriaVIH/sidapublié 2025African health sciencesPubMeddocument de 7 observations
18,8 %Three (18.8%) of 16 participants were HIV-1 positive.
NigeriaVIH/sidaobservé 2017-2018publié 2022International journal of STD & AIDSPubMeddocument de 8 observations
22,7 %The prevalence of partial disclosure of HIV status to children in Abuja, Nigeria was 22.7%.
NigeriaVIH/sidaobservé 2016publié 2020Nigerian journal of clinical practicePubMeddocument de 5 observations
40 %By increasing the annual number of HIV counseling and testing (HCT) services by 100 percent, the unit cost decreases by 40 percent.
NigeriaVIH/sidapublié 2023PloS onePubMeddocument de 10 observations
44 %22 (44%) of the 50 men were classified as people living with HIV.
NigeriaVIH/sidaHAL · Unilimdocument de 102 observations
There was a sharp decline in performance in adherence assessment to antiretroviral drugs between 2010 and 2012, with p < 0.01.
NigeriaVIH/sidaobservé 2010 to 2012publié 2019AIDS research and therapyPubMeddocument de 5 observations
7 361 individualsThe latent class analysis identified four distinct subgroups of adolescents and young adults based on patterns of barriers to HIV testing: 'low-risk perception' (n = 7,361; 39.5%), 'consent and proximity' (n = 5,163; 27.74%), 'testing site' (n = 4,996; 26.84%), and 'cost and logistics' (n = 1,092; 5.87%).
NigeriaVIH/sidaobservé 2018publié 2024PloS onePubMeddocument de 15 observations
4,22 aORFemale sex workers residing in the North East geopolitical zone of Nigeria had higher odds of prenatal HIV testing compared to those in the South South zone (adjusted odds ratio = 4.22).
NigeriaVIH/sidapublié 2024International journal of STD & AIDSPubMeddocument de 12 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.